company background image
HIMS logo

Hims & Hers Health NYSE:HIMS Rapporto sulle azioni

Ultimo prezzo

US$23.62

Cap. di mercato

US$5.1b

7D

25.4%

1Y

256.3%

Aggiornato

07 Nov, 2024

Dati

Dati finanziari dell'azienda +

Hims & Hers Health, Inc.

NYSE:HIMS Rapporto sulle azioni

Cap. di mercato: US$5.1b

HIMS Panoramica delle azioni

Hims & Hers Health, Inc. gestisce una piattaforma di teleassistenza che mette in contatto i consumatori con professionisti sanitari autorizzati negli Stati Uniti, nel Regno Unito e a livello internazionale.

HIMS analisi fondamentale
Punteggio fiocco di neve
Valutazione3/6
Crescita futura5/6
Prestazioni passate4/6
Salute finanziaria6/6
Dividendi0/6

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

US$24.17
FV
2.3% undervalued intrinsic discount
29.31%
Revenue growth p.a.
3users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
1 day ago author updated this narrative
US$17.15
FV
37.7% overvalued intrinsic discount
100.00%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
4 months ago author updated this narrative

Hims & Hers Health, Inc. Concorrenti

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Hims & Hers Health
Prezzi storici delle azioni
Prezzo attuale dell'azioneUS$23.62
Massimo di 52 settimaneUS$25.74
Minimo di 52 settimaneUS$6.58
Beta1.06
1Variazione di 1 mese25.97%
Variazione a 3 mesi48.00%
Variazione di 1 anno256.26%
3Variazione a 3 anni206.75%
Variazione a 5 anni139.80%
Variazione dall'IPO141.02%

Notizie e aggiornamenti recenti

Hims & Hers: A Lot More Than Just GLP-1, And It's Proving Its Ability To Grow

Nov 05

HIMS: GLP-1 Is Just The Beginning

Oct 17

Recent updates

Hims & Hers: A Lot More Than Just GLP-1, And It's Proving Its Ability To Grow

Nov 05

HIMS: GLP-1 Is Just The Beginning

Oct 17

Hims & Hers: Shortage Saga Brings Stupendous Risk-Reward

Oct 03

Hims & Hers Health, Inc.'s (NYSE:HIMS) P/S Is Still On The Mark Following 25% Share Price Bounce

Oct 01
Hims & Hers Health, Inc.'s (NYSE:HIMS) P/S Is Still On The Mark Following 25% Share Price Bounce

Hims & Hers Is Unbelievably Cheap And Profitable: Buy Now

Sep 24

Hims & Hers Health Post Q2 Earnings - Compounded GLP-1 Ploy Faces New Threats (Rating Downgrade)

Aug 27

Hims & Hers: Digesting Q2 2024 Earnings, Shares Still Undervalued, Rating Downgrade

Aug 20

Hims & Hers Health, Inc.'s (NYSE:HIMS) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Aug 11
Hims & Hers Health, Inc.'s (NYSE:HIMS) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Hims & Hers Health: Buy The Dip, With Or Without The GLP-1 Shortage

Aug 07

Hims & Hers: The Thesis Goes Far Beyond GLP-1

Jul 18

Hims & Hers: Buy The Dip To Catch The Next Rip

Jun 24

Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 70% Share Price Surge

Jun 19
Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 70% Share Price Surge

Hims & Hers: The Undervalued Gem Poised For Growth

Jun 18

Beyond The Marketing Machine: Why Hims & Hers Stock Might Be Vulnerable

Jun 10

Hims & Hers Health, Inc.'s (NYSE:HIMS) CEO Compensation Is Looking A Bit Stretched At The Moment

May 31
Hims & Hers Health, Inc.'s (NYSE:HIMS) CEO Compensation Is Looking A Bit Stretched At The Moment

Hims & Hers: Soaring On Access To Compounded GLP-1 Drugs, Further Volatility Ahead

May 21

Hims & Hers Health: An Unforced Error

May 06

Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

May 04
Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

Hims & Hers Health: Becoming A Market Leader Within The Growing Digital Health Industry

Apr 24

Hims & Hers Health: Strong Prospects But Weak Business Model Consolidation

Apr 05

Hims & Hers: 5 Reasons Why This Is A Phenomenal Long-Term Growth Stock

Mar 21

Pills Pay The Bills: Mini Deep Dive On Hims & Hers Health

Mar 12

Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%

Feb 28
Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%

Hims & Hers: Turning The Profitability Corner And Returning 28%

Feb 25

Hims & Hers Health: No Clear Moat Besides First Mover Advantage

Jan 23

Hims & Hers Health: Unleashing Macro Momentum - Investing In Growth At A Higher Multiple

Jan 10

Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)

Jan 07
Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)

Hims & Hers Health Q3: The Cheapest Growth Stock Around

Dec 14

Hims & Hers Health: What Would The Author Of 100 Baggers Say?

Nov 30

Hims & Hers: The Most Undervalued Small Cap Stock I See

Nov 08

Hims & Hers: A Promising Company With Resolvable Challenges

Nov 02

Hims & Hers: Specialization Is The Secret To Great Growth

Oct 25

Hims & Hers Health: Can't Get Much Better

Sep 25

The Market Is Wrong On Hims & Hers Health

Sep 18

Hims & Hers: The Current Weakness Creates A Buying Opportunity

Aug 15

Rendimenti per gli azionisti

HIMSUS HealthcareUS Mercato
7D25.4%5.6%5.1%
1Y256.3%7.3%37.7%

Ritorno vs Industria: HIMS ha superato il US Healthcare che ha restituito 7.3 % nell'ultimo anno.

Rendimento vs Mercato: HIMS ha superato il mercato US che ha restituito 37.7 % nell'ultimo anno.

Volatilità dei prezzi

Is HIMS's price volatile compared to industry and market?
HIMS volatility
HIMS Average Weekly Movement10.7%
Healthcare Industry Average Movement6.8%
Market Average Movement6.2%
10% most volatile stocks in US Market15.1%
10% least volatile stocks in US Market2.9%

Prezzo delle azioni stabile: Il prezzo delle azioni di HIMS è stato volatile negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 11% ) di HIMS è rimasta stabile nell'ultimo anno, ma è comunque superiore al 75% delle azioni US.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
n/a1,046Andrew Dudumwww.forhims.com

Hims & Hers Health, Inc. gestisce una piattaforma di teleassistenza che mette in contatto i consumatori con professionisti sanitari autorizzati negli Stati Uniti, nel Regno Unito e a livello internazionale. L'azienda offre una serie di prodotti e servizi per la salute e il benessere, con o senza prescrizione medica, acquistabili direttamente dai clienti sui suoi siti web e sulle sue applicazioni mobili. Fornisce anche farmaci su prescrizione su base ricorrente e assistenza continua da parte di fornitori di assistenza sanitaria; e prodotti da banco, farmaci e dispositivi, cosmetici e integratori incentrati principalmente su benessere generale, salute e benessere sessuale, cura della pelle e dei capelli.

Hims & Hers Health, Inc. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Hims & Hers Health con la sua capitalizzazione di mercato?
HIMS statistiche fondamentali
Capitalizzazione di mercatoUS$5.12b
Guadagni(TTM)US$101.26m
Ricavi(TTM)US$1.24b

51.0x

Rapporto P/E

4.2x

Rapporto P/S

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
HIMS Conto economico (TTM)
RicaviUS$1.24b
Costo del fatturatoUS$234.34m
Profitto lordoUS$1.01b
Altre speseUS$906.39m
GuadagniUS$101.26m

Ultimi guadagni dichiarati

Sep 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)0.46
Margine lordo81.13%
Margine di profitto netto8.15%
Rapporto debito/patrimonio netto0%

Come si è comportato HIMS nel lungo periodo?

Vedi performance storica e confronto